Biopharmaceutical
Process Development
|
Biopharmaceutical
|
||
|
|
| Recent technological advances in genomics, proteomics, target validation and lead compound identification have created an escalating need for contract services along the entire length of the development pipeline, from basic research and preclinical development to clinical trials, FDA approval and commercialization. | ||||
|
Paragon is a GLP-compliant, cost-effective, and expedient outsourcing partner to assist you through drug discovery and preclinical development. 
|
||||
| Paragon Home Page | ||||
| Process Development | ||||
| For Recombinant Protein |
||||
| Process Development Capacity |
||||
| Related Links | ||||
| Recombinant Protein Expression |
||||
| Protein Purification | ||||
| Virus
Production & Purification |
||||
| Functional
Assays & Assay Development |
||||
| By forming contractual alliances, Paragon is positioned to assist pharmaceutical and biotechnology companies, and biotech start-ups, in accelerating drug discovery and preclinical development. | ||||
|
|
||||
|
|
Paragon Bioservices, Inc -
Johns Hopkins Bayview Research Campus Alpha Center - 5210 Eastern Avenue - Baltimore, Maryland 21224 800.545.6569 - 410.550.2919 - 410.550.2924 (fax) NIH BPA#: 263-00054123 - www.paragonbioservices.com - pbi@paragonbioservices.com |
|||
|
© 2003 Paragon Bioservices, Inc. |
||||